$AFMD News Article - Affimed Announces First Patient Successfully Dosed in the First-in-Human Study of AFM28 for the Treatment of Patients with Relapsed / Refractory CD123-Positive Acute Myeloid Leukemia
https://marketwirenews.com/news-releases/affi...72653.html